These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3276052)

  • 1. Treatment of chronic renal allograft rejection with cyclosporine and prednisone.
    Rosenblum ND; Harmon WE; Levey RH
    Transplantation; 1988 Jan; 45(1):232-4. PubMed ID: 3276052
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract]   [Full Text] [Related]  

  • 3. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
    Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
    [No Abstract]   [Full Text] [Related]  

  • 4. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
    MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
    [No Abstract]   [Full Text] [Related]  

  • 5. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
    Light JA; Aquino A; Ali A; Rodriguez R; Ali S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.
    Feduska NJ; Melzer J; Amend WJ; Vincenti F; Tomlanovich S; Salvatierra O
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):136-40. PubMed ID: 3515681
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential conventional immunotherapy with maintenance cyclosporine following renal transplantation.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):69-75. PubMed ID: 3515698
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
    Paraiso AR; Ona ET; Alano FA; Ramos CP; De Luna M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy.
    Stiller C; Keown P
    Transplant Proc; 1990 Jun; 22(3):1253-4. PubMed ID: 2349687
    [No Abstract]   [Full Text] [Related]  

  • 10. T-lymphocyte subsets in renal allograft recipients treated with cyclosporine and azathioprine.
    Sumpio BE; Dwyer JM; Flye MW
    Ann Surg; 1987 Jan; 205(1):49-53. PubMed ID: 3541801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperuricemia after renal transplantation.
    Gores PF; Fryd DS; Sutherland DE; Najarian JS; Simmons RL
    Am J Surg; 1988 Nov; 156(5):397-400. PubMed ID: 3056057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with cyclosporine and prednisone as immunosuppressants in 36 renal transplants.
    Kovithavongs T; Boake R; Lakey WH; Ulan RA; Dossetor JB
    Transplant Proc; 1984 Aug; 16(4):1083-5. PubMed ID: 6380055
    [No Abstract]   [Full Text] [Related]  

  • 13. Triple therapy including cyclosporine A versus conventional regimen--a randomized prospective study in pediatric kidney transplantation.
    Broyer M; Gagnadoux MF; Guest G; Niaudet P
    Transplant Proc; 1987 Oct; 19(5):3582-5. PubMed ID: 3313862
    [No Abstract]   [Full Text] [Related]  

  • 14. [A comparative trial of OKT3 and antilymphocyte serum in the preventive treatment of rejection after kidney transplantation in children].
    Niaudet P; Murcia I; Jean G; Broyer M
    Ann Pediatr (Paris); 1990 Feb; 37(2):83-5. PubMed ID: 2138866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single center experience with "low-dose" cyclosporine in cadaveric renal transplantation.
    Fries D; Hiesse C; Charpentier B; Lantz O; Bensadoun H; Benoit G
    Clin Transpl; 1988; ():115-29. PubMed ID: 3154465
    [No Abstract]   [Full Text] [Related]  

  • 16. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine.
    Canafax DM; Simmons RL; Sutherland DE; Fryd DS; Strand MH; Ascher NL; Payne WD; Najarian JS
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):192-6. PubMed ID: 3515687
    [No Abstract]   [Full Text] [Related]  

  • 17. Beneficial effects of cyclosporine compared with azathioprine in cadaveric renal transplantation.
    Henry ML; Sommer BG; Ferguson RM
    Am J Surg; 1985 Nov; 150(5):533-6. PubMed ID: 2998215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients.
    Awni WM; Heim-Duthoy K; Kasiske BL
    Transplant Proc; 1990 Jun; 22(3):1343-4. PubMed ID: 2349693
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of azathioprine-antilymphocyte globulin versus cyclosporine in renal transplantation.
    Sutherland DE; Strand M; Fryd DS; Ferguson RM; Simmons RL; Ascher NL; Najarian JS
    Am J Kidney Dis; 1984 May; 3(6):456-61. PubMed ID: 6372449
    [No Abstract]   [Full Text] [Related]  

  • 20. Current results with triple therapy for heart transplantation.
    Bolman RM; Olivari MT; Saffitz J; Sibley R; Spadaro J; Cance C; Elick B
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2490-1. PubMed ID: 3274544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.